504 related articles for article (PubMed ID: 29274754)
61. Low performance of bleeding risk models in the very elderly with atrial fibrillation using vitamin K antagonists.
Jaspers Focks J; van Vugt SP; Albers-Akkers MT; Lamfers EJ; Bloem-de Vries LM; Verheugt FW; Brouwer MA
J Thromb Haemost; 2016 Sep; 14(9):1715-24. PubMed ID: 27172860
[TBL] [Abstract][Full Text] [Related]
62. Comparison of HAS-BLED with other risk models for predicting the bleeding risk in anticoagulated patients with atrial fibrillation: A PRISMA-compliant article.
Zeng J; Yu P; Cui W; Wang X; Ma J; Zeng C
Medicine (Baltimore); 2020 Jun; 99(25):e20782. PubMed ID: 32569222
[TBL] [Abstract][Full Text] [Related]
63. Bleeding risk assessment in patients with atrial fibrillation who are taking oral anticoagulants.
Guo Y; Lip GY; Apostolakis S
Hosp Pract (1995); 2013 Feb; 41(1):71-8. PubMed ID: 23466969
[TBL] [Abstract][Full Text] [Related]
64. Management of Major Bleeding in Patients With Atrial Fibrillation Treated With Non-Vitamin K Antagonist Oral Anticoagulants Compared With Warfarin in Clinical Practice (from Phase II of the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation [ORBIT-AF II]).
Steinberg BA; Simon DN; Thomas L; Ansell J; Fonarow GC; Gersh BJ; Kowey PR; Mahaffey KW; Peterson ED; Piccini JP;
Am J Cardiol; 2017 May; 119(10):1590-1595. PubMed ID: 28363354
[TBL] [Abstract][Full Text] [Related]
65. The SAMe-TT2R2 Score Predicts Poor Anticoagulation Control in AF Patients: A Prospective 'Real-world' Inception Cohort Study.
Roldán V; Cancio S; Gálvez J; Valdés M; Vicente V; Marín F; Lip GY
Am J Med; 2015 Nov; 128(11):1237-43. PubMed ID: 26087049
[TBL] [Abstract][Full Text] [Related]
66. Effects of Oral Anticoagulant Therapy in Medical Inpatients ≥65 Years With Atrial Fibrillation.
Bo M; Sciarrillo I; Li Puma F; Badinella Martini M; Falcone Y; Iacovino M; Grisoglio E; Menditto E; Fonte G; Brunetti E; Maggiani G; Isaia GC; Gaita F
Am J Cardiol; 2016 Feb; 117(4):590-595. PubMed ID: 26718230
[TBL] [Abstract][Full Text] [Related]
67. Left Atrial Appendage Occlusion Versus Oral Anticoagulation in Atrial Fibrillation : A Decision Analysis.
Chew DS; Zhou K; Pokorney SD; Matchar DB; Vemulapalli S; Allen LA; Jackson KP; Samad Z; Patel MR; Freeman JV; Piccini JP
Ann Intern Med; 2022 Sep; 175(9):1230-1239. PubMed ID: 35969865
[TBL] [Abstract][Full Text] [Related]
68. Vitamin K and non-vitamin K antagonist oral anticoagulants for non-valvular atrial fibrillation in real-life.
Giustozzi M; Vedovati MC; Verdecchia P; Pierpaoli L; Verso M; Conti S; Cianella F; Marchesini E; Filippucci E; Agnelli G; Becattini C
Eur J Intern Med; 2016 Sep; 33():42-6. PubMed ID: 27394924
[TBL] [Abstract][Full Text] [Related]
69. Comparison of the HAS-BLED versus ORBIT scores in predicting major bleeding among Asians receiving direct-acting oral anticoagulants.
Wattanaruengchai P; Nathisuwan S; Karaketklang K; Wongcharoen W; Phrommintikul A; Lip GYH
Br J Clin Pharmacol; 2022 May; 88(5):2203-2212. PubMed ID: 34783372
[TBL] [Abstract][Full Text] [Related]
70. Bleeding risk in 'real world' patients with atrial fibrillation: comparison of two established bleeding prediction schemes in a nationwide cohort.
Olesen JB; Lip GY; Hansen PR; Lindhardsen J; Ahlehoff O; Andersson C; Weeke P; Hansen ML; Gislason GH; Torp-Pedersen C
J Thromb Haemost; 2011 Aug; 9(8):1460-7. PubMed ID: 21624047
[TBL] [Abstract][Full Text] [Related]
71. Relationship of the ORBIT and HAS-BLED scores with Killip class 3-4 in patients with ST-segment elevation myocardial infarction.
Zhang Q; Zhou L; Cai HL; Lu HH
Medicine (Baltimore); 2019 Feb; 98(8):e14578. PubMed ID: 30813174
[TBL] [Abstract][Full Text] [Related]
72. Joint use of cardio-embolic and bleeding risk scores in elderly patients with atrial fibrillation.
Marcucci M; Nobili A; Tettamanti M; Iorio A; Pasina L; Djade CD; Franchi C; Marengoni A; Salerno F; Corrao S; Violi F; Mannucci PM;
Eur J Intern Med; 2013 Dec; 24(8):800-6. PubMed ID: 24035703
[TBL] [Abstract][Full Text] [Related]
73. Development of a novel composite stroke and bleeding risk score in patients with atrial fibrillation: the AMADEUS Study.
Lip GYH; Lane DA; Buller H; Apostolakis S
Chest; 2013 Dec; 144(6):1839-1847. PubMed ID: 24009027
[TBL] [Abstract][Full Text] [Related]
74. Reviewing a clinical decision aid for the selection of anticoagulation treatment in patients with nonvalvular atrial fibrillation: applications in a US managed care health plan database.
Deitelzweig SB; Jing Y; Swindle JP; Makenbaeva D
Clin Ther; 2014 Nov; 36(11):1566-1573.e3. PubMed ID: 25438725
[TBL] [Abstract][Full Text] [Related]
75. Prevalence, main determinants, and early outcome of patients with atrial fibrillation hospitalized with ischemic stroke: evaluation of the value of risk assessment scores for predicting risk of stroke or major bleeding following anticoagulation therapy.
Sadeghi R; Parsa Mahjoob M; Asadollahi M; Abbasi Z
Acta Biomed; 2015 Sep; 86(2):162-9. PubMed ID: 26422431
[TBL] [Abstract][Full Text] [Related]
76. [Anticoagulation and new therapeutic options in atrial fibrillation].
Mischke K
Dtsch Med Wochenschr; 2016 Oct; 141(22):1618-1623. PubMed ID: 27824417
[TBL] [Abstract][Full Text] [Related]
77. Do CHA2 DS2 VASc and HAS-BLED scores influence 'real-world' anticoagulation management in atrial fibrillation? 1556 patient registry from the reference cardiology centre.
Lopatowska P; Tomaszuk-Kazberuk A; Mlodawska E; Bachorzewska-Gajewska H; Malyszko J; Dobrzycki S; Musial WJ
Pharmacoepidemiol Drug Saf; 2015 Dec; 24(12):1297-303. PubMed ID: 26419506
[TBL] [Abstract][Full Text] [Related]
78. [Comparison of the HAS-BLED and ATRIA scores for the risk of bleeding in patients aged 75 and over receiving vitamin K antagonist (VKA) therapy and educated VKA-management].
Soave C; Chidlovskii E; Lebelhomme A; Gaboreau Y; Pernod G; Bosson JL; Couturier P
Geriatr Psychol Neuropsychiatr Vieil; 2015 Sep; 13(3):279-88. PubMed ID: 26395301
[TBL] [Abstract][Full Text] [Related]
79. Is the prescription right? A review of non-vitamin K antagonist anticoagulant (NOAC) prescriptions in patients with non-valvular atrial fibrillation. Safe prescribing in atrial fibrillation and evaluation of non-vitamin K oral anticoagulants in stroke prevention (SAFE-NOACS) group.
Pharithi RB; Ranganathan D; O'Brien J; Egom EE; Burke C; Ryan D; McAuliffe C; Vaughan M; Coughlan T; Morrissey E; McHugh J; Moore D; Collins R
Ir J Med Sci; 2019 Feb; 188(1):101-108. PubMed ID: 29860595
[TBL] [Abstract][Full Text] [Related]
80. Risk profiles and pattern of antithrombotic use in patients with non-valvular atrial fibrillation in Thailand: a multicenter study.
Krittayaphong R; Winijkul A; Methavigul K; Wongtheptien W; Wongvipaporn C; Wisaratapong T; Kunjara-Na-Ayudhya R; Boonyaratvej S; Komoltri C; Kaewcomdee P; Yindeengam A; Sritara P;
BMC Cardiovasc Disord; 2018 Aug; 18(1):174. PubMed ID: 30144802
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
